SCHEDULE: KKR Sells 14.7M BrightSpring Shares, Reduces Stake to 34.5%

KKR Phoenix Aggregator L.P. sold 14.7 million shares of BrightSpring Health Services common stock in a secondary offering, reducing its beneficial ownership to 34.5%.

Summary

• KKR Phoenix Aggregator L.P., a selling stockholder, entered into an underwriting agreement on October 20, 2025, to sell 14,745,000 shares of BrightSpring Health Services, Inc. common stock.
• The offering involved a total of 15,000,000 shares sold by various selling stockholders, with KKR Phoenix Aggregator L.P. being the primary seller.
• The shares were sold at a net price of $28.7820 per share to KKR Phoenix Aggregator L.P., totaling approximately $424.4 million.
• The offering closed on October 22, 2025.
• Following the offering, KKR Phoenix Aggregator L.P. directly holds 61,942,032 shares of Common Stock, representing approximately 34.5% of the outstanding shares.
• The calculation of beneficial ownership is based on an aggregate of 179,800,317 shares of Common Stock outstanding after the offering.
• KKR Phoenix Aggregator L.P. entered into a lock-up agreement, restricting further sales of Common Stock for 60 days from October 20, 2025.
• KKR Phoenix Aggregator L.P. and its affiliates also initiated in-kind distributions of 409,305 shares of Common Stock to their partners and shareholders for charitable donations.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative. While the offering provides liquidity for KKR, a major shareholder reducing its stake can be perceived as a lack of stronger conviction in the company's immediate future, potentially creating uncertainty for other investors. The price achieved is positive for KKR, but the impact on BrightSpring's stock price could be negative due to increased supply.

Positives

• The secondary offering provided liquidity for KKR Phoenix Aggregator L.P. and its affiliates, allowing them to monetize a portion of their investment at a price of $28.7820 per share.
• The sale of shares by a major holder can increase the public float and potentially improve liquidity for BrightSpring Health Services' stock.

Negatives

• A significant reduction in ownership by a major institutional investor like KKR could be perceived by the market as a signal of reduced long-term conviction or a move towards a full exit.
• The increased supply of shares in the market from the secondary offering could exert downward pressure on the stock price in the short term.

Risks

• The lock-up agreement restricts KKR Phoenix Aggregator L.P. from selling additional shares for 60 days, but after this period, further sales could occur, potentially impacting the stock price.
• A large shareholder reducing its stake may lead to questions about the company's future growth prospects or KKR's strategic involvement.

Future Outlook

KKR Phoenix Aggregator L.P. is restricted from offering, selling, or otherwise disposing of additional shares of Common Stock for a period of 60 days following October 20, 2025, due to a lock-up agreement with the underwriter.

Industry Context

This secondary offering by KKR is a typical private equity strategy to monetize a portion of its investment in a portfolio company after an IPO. Such sales are common as private equity firms manage their fund cycles and seek to return capital to their limited partners. BrightSpring Health Services operates in the healthcare services sector, where private equity involvement is significant.

Comparison to Industry Standards

• The sale of a significant stake by a private equity sponsor like KKR is a standard practice in the lifecycle of a private equity investment, particularly following an initial public offering (IPO).
• The lock-up agreement for 60 days is a customary provision in secondary offerings to stabilize the market price post-sale, similar to those seen in offerings by other private equity-backed companies in the healthcare or other sectors.

Related Party Transactions

• KKR Phoenix Aggregator L.P. and its affiliates distributed 409,305 shares of Common Stock as in-kind distributions to their respective partners and shareholders, including foundations and trusts associated with Messrs. Kravis, Roberts, Bae, and Nuttall, for charitable donation purposes.

Stakeholder Impact

• Shareholders: The secondary offering increases the public float, potentially improving liquidity, but also introduces a large block of shares into the market, which could create selling pressure. The reduction in KKR's stake might alter perceptions of institutional support.
• KKR Phoenix Aggregator L.P. and its affiliates: Successfully monetized a significant portion of their investment, realizing proceeds of approximately $424.4 million.

Next Steps

• The lock-up period for KKR Phoenix Aggregator L.P. will expire 60 days after October 20, 2025, after which further sales of shares could occur.

Key Dates

Recommendation

The filing details a significant secondary offering by a major institutional investor, KKR, reducing its stake in BrightSpring Health Services. While this provides liquidity for KKR, it can introduce uncertainty for other investors regarding KKR's long-term commitment and potentially create short-term selling pressure on the stock. Without additional information on BrightSpring's operational performance or strategic outlook, a 'hold' recommendation is prudent, advising investors to monitor the market's absorption of the new shares and any subsequent signals from KKR or company management.

Keywords

BrightSpring Health Services, KKR, Secondary Offering, Share Sale, Beneficial Ownership, Schedule 13D, Equity Offering, Institutional Investor, Healthcare Services